India 2020 India

₹260 crore profit for Jan-Mar

Reading now: 858
www.livemint.com

Jubilant Life reported a consolidated net profit of ₹260.49 crore for the quarter ended on 31 March 2020 as against a net loss of ₹100.65 crore for the corresponding period of the previous fiscal Drug firm Jubilant Life Sciences on Friday reported a consolidated net profit of ₹260.49 crore for the quarter ended on 31 March 2020, driven by robust sales in pharmaceuticals segment.

The company had posted a net loss of ₹100.65 crore for the corresponding period of the previous fiscal, Jubilant Life Sciences said in a filing to BSE.

Consolidated revenue from operations stood at ₹2,391.41 crore for the quarter under consideration as against ₹2,385.58 crore for the same period year ago, it added.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA